Hanna Dennis, PA
Physician Assistant · Hollywood, MDNPI 1831406883
Payments from drug & device makers
Across 156 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$736
- Lilly USA, LLC$318
- Corcept Therapeutics$281
- Abbott$162
- Exact Sciences$136
- AstraZeneca$134
- plus $776 from 18 others
What the payments were for
- Food & beverage$2,544100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $736 |
| Lilly USA, LLC | 15 | $318 |
| Corcept Therapeutics | 11 | $281 |
| Abbott | 4 | $162 |
| Exact Sciences | 6 | $136 |
| AstraZeneca(2 entities) | 6 | $134 |
| Novo Nordisk | 6 | $120 |
| Pfizer | 5 | $89 |
| Boehringer Ingelheim | 1 | $80 |
| Amgen | 3 | $75 |
| Novartis | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| GSK | 2 | $42 |
| UCB, Inc. | 2 | $32 |
| Dynavax Technologies Corporation | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,544 in reported general payments places this provider in the 85th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $33,718 |
| VraylarCariprazine Hcl | 12 | $14,725 |
| MounjaroTirzepatide | 14 | $14,677 |
| FarxigaDapagliflozin Propanediol | 13 | $10,890 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,380 |
| Rosuvastatin Calcium | 90 | $1,912 |
| Atorvastatin Calcium | 138 | $1,617 |
| Trazodone Hcl | 53 | $1,601 |
| Famotidine | 82 | $1,595 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 15 | $1,517 |
| SynthroidLevothyroxine Sodium | 14 | $1,432 |
| Amlodipine Besylate | 119 | $1,339 |
| Valsartan | 38 | $1,223 |
| Chlorthalidone | 20 | $920 |
| Levocetirizine Dihydrochloride | 22 | $911 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $120 | $33,71817 claims |
| AbbVieVraylar, Synthroid | $736 | $16,15626 claims |
| Lilly USA, LLCMounjaro | $318 | $14,67714 claims |
| AstraZenecaFarxiga | $134 | $10,89013 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $20 | $1,22338 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Hollywood
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.